Integration of Family Planning and HIV Services in Tanzania

NCT ID: NCT00941876

Last Updated: 2011-08-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

864 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-08-31

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

HIV positive women and couples have broad reproductive health needs that are not always met within HIV services. The integration of family planning (FP) services into Tanzania's HIV Care and Treatment Clinics (CTC) will address the fertility desires of CTC clients and ultimately result in the reduction of unintended pregnancies and HIV incidence. One strategy for integrating FP and CTC services is to use a "facilitated referral" model. Facilitated referrals are enhanced referrals for additional services that have been used in other settings and which are the preferred intervention strategy the Government of Tanzania would like to pilot test. This study will evaluate the feasibility, effectiveness, and costs of implementing a "facilitated referrals" intervention by examining FP use among female clients attending HIV/AIDS Care and Treatment Centers. This study will measure whether there is a reduction in unmet need for contraception among female CTC clients after the facilitated referral integration intervention has been implemented.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infection HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A. Facilitated Referral

Seven key steps carried out by CTC and FP staff to encourage completion of FP referral by CTC.

Group Type EXPERIMENTAL

Facilitated Referral

Intervention Type BEHAVIORAL

Seven key steps carried out by CTC and FP staff to encourage completion of FP referral by CTC.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Facilitated Referral

Seven key steps carried out by CTC and FP staff to encourage completion of FP referral by CTC.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Female clients of Care \& Treatment Clinics with CD4 counts \>100, and are WHO Stage I - III. (CTC Clients)
2. Care and Treatment providers who provide services to clients (CTC Providers)
3. Care and Treatment supervisors who are the immediate in-charge supervisor for the CTC clinic. (CTC supervisor)
4. Family Planning providers who provide services to clients. (FP providers)
5. Family Planning supervisors who are the immediate in-charge supervisor for the FP clinic. (FP supervisor)
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Muhimbili University of Health and Allied Sciences

OTHER

Sponsor Role collaborator

FHI 360

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

FHI

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joy N Bumgartner, MSW, PhD

Role: PRINCIPAL_INVESTIGATOR

FHI 360

Thecla W Kohi, PhD

Role: PRINCIPAL_INVESTIGATOR

Muhimbili University of Health and Allied Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Muhimbili University of Health and Allied Services

Dar es Salaam, , Tanzania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Tanzania

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10121

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rudi Kundini, Pamoja Kundini
NCT05373095 ACTIVE_NOT_RECRUITING NA
Male Engagement in PMTCT Services
NCT01903889 COMPLETED NA